Literature DB >> 3513228

Breast reconstruction using modified tissue expansion.

G O Dick, S A Brown.   

Abstract

Inadequate chest-wall skin following mastectomy for carcinoma continues to be a problem in many breast reconstructions. To avoid extensive surgery, serial tissue expansion has been advocated. Since 1977, one of the authors has used a simple method of tissue expansion that we have termed "modified tissue expansion", defined as the creation of an adequate breast mound in one or two stages using a permanent prosthesis. Ninety percent of patients undergoing breast reconstruction between 1978 and 1983 were reconstructed using this method. A retrospective analysis of these 208 patients is presented. There were no mortalities, and only a 6.3 percent complication rate. Skin necroses related directly to the prosthesis occurred once, and there were no prosthetic deflations. Eighteen percent had first-step reconstruction only. The initial prosthesis averaged 400 cc in size. Selected Halsted radical mastectomy and postradiotherapy patients were successfully reconstructed. Seventy-eight percent felt their results were excellent at 1 year. Two percent were dissatisfied. Multiple office visits and the potential problems of serial expansion were avoided. Modified tissue expansion is a simple and viable method and should be considered among the options for breast reconstruction following mastectomy.

Entities:  

Mesh:

Year:  1986        PMID: 3513228     DOI: 10.1097/00006534-198604000-00017

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  2 in total

1.  Immediate breast reconstruction-impact on radiation management.

Authors:  Ravi A Shankar; J Rao Nibhanupudy; Rajagopalan Sridhar; Cori Ashton; Alfred L Goldson
Journal:  J Natl Med Assoc       Date:  2003-04       Impact factor: 1.798

2.  Postoperative irradiation following immediate breast reconstruction using a temporary tissue expander.

Authors:  W B Jackson; A L Goldson; C Staud
Journal:  J Natl Med Assoc       Date:  1994-07       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.